GB Patent

GB202211142D0 — Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof

Assigned to Macfarlan Smith Ltd · Expires 2022-09-14 · 4y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: GB202211142D0
Jurisdiction: GB
Classification: —
Expires: 2022-09-14
Drug substance claim: No
Drug product claim: No
Assignee: Macfarlan Smith Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.